Neuberger Berman Group LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Neuberger Berman Group LLC holds 259,667 shares of XBI stock, worth $24.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

259,667

Previous 260,966 0.5%

Holding current value

$24.6 Million

Previous $24.2 Million 6.04%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$90.87 - $102.43 $118,040 - $133,056	-1,299 Reduced 0.5%	259,667 $25.7 Million
Q2 2024 Nov 14, 2024	BUY	$82.22 - $94.12 $2.17 Million - $2.48 Million	26,359 Added 11.24%	260,966 $24.2 Million
Q2 2024 Aug 13, 2024	BUY	$82.22 - $94.12 $2.17 Million - $2.48 Million	26,359 Added 11.24%	260,966 $24.2 Million
Q1 2024 Nov 14, 2024	SELL	$87.05 - $102.89 $1.01 Million - $1.19 Million	-11,590 Reduced 4.71%	234,607 $22.3 Million
Q1 2024 May 13, 2024	BUY	$87.05 - $102.89 $20.4 Million - $24.1 Million	234,607 New	234,607 $22.3 Million
Q4 2023 Nov 14, 2024	SELL	$64.12 - $90.86 $946,988 - $1.34 Million	-14,769 Reduced 5.66%	246,197 $22 Million
Q4 2023 Feb 09, 2024	BUY	$64.12 - $90.86 $14.3 Million - $20.3 Million	223,081 Added 965.05%	246,197 $22 Million
Q3 2023 Nov 14, 2023	SELL	$71.88 - $85.76 $81,943 - $97,766	-1,140 Reduced 4.7%	23,116 $1.69 Million
Q2 2023 Aug 11, 2023	SELL	$75.38 - $90.23 $15,528 - $18,587	-206 Reduced 0.84%	24,256 $2.02 Million
Q1 2023 May 12, 2023	BUY	$73.13 - $91.97 $22,012 - $27,682	301 Added 1.25%	24,462 $1.86 Million
Q4 2022 Feb 13, 2023	SELL	$76.72 - $85.66 $167,863 - $187,424	-2,188 Reduced 8.3%	24,161 $2.01 Million
Q3 2022 Nov 15, 2022	SELL	$75.06 - $94.9 $383,181 - $484,464	-5,105 Reduced 16.23%	26,349 $2.09 Million
Q2 2022 Aug 15, 2022	SELL	$62.81 - $96.09 $1.19 Million - $1.82 Million	-18,905 Reduced 37.54%	31,454 $2.34 Million
Q1 2022 May 13, 2022	SELL	$81.07 - $115.44 $651,316 - $927,444	-8,034 Reduced 13.76%	50,359 $4.49 Million
Q4 2021 Feb 11, 2022	SELL	$108.77 - $134.15 $204,596 - $252,336	-1,881 Reduced 3.12%	58,393 $6.54 Million
Q3 2021 Nov 12, 2021	BUY	$118.69 - $138.49 $513,452 - $599,107	4,326 Added 7.73%	60,274 $7.58 Million
Q2 2021 Aug 13, 2021	BUY	$122.48 - $139.69 $1.08 Million - $1.23 Million	8,778 Added 18.61%	55,948 $7.58 Million
Q1 2021 May 13, 2021	BUY	$129.36 - $173.99 $111,249 - $149,631	860 Added 1.86%	47,170 $6.4 Million
Q4 2020 Feb 10, 2021	BUY	$110.36 - $151.14 $443,095 - $606,827	4,015 Added 9.49%	46,310 $6.52 Million
Q3 2020 Nov 12, 2020	BUY	$103.87 - $120.36 $94,521 - $109,527	910 Added 2.2%	42,295 $0
Q2 2020 Aug 13, 2020	SELL	$73.26 - $114.17 $647,252 - $1.01 Million	-8,835 Reduced 17.59%	41,385 $4.63 Million
Q1 2020 May 14, 2020	BUY	$65.95 - $98.35 $532,348 - $793,881	8,072 Added 19.15%	50,220 $0
Q4 2019 Feb 12, 2020	BUY	$74.65 - $98.46 $1.36 Million - $1.8 Million	18,278 Added 76.57%	42,148 $4.01 Million
Q3 2019 Nov 13, 2019	BUY	$76.25 - $83.86 $45,750 - $50,316	600 Added 2.58%	23,870 $1.82 Million
Q2 2019 Aug 13, 2019	BUY	N/A	11,600 Added 99.4%	23,270 $2.04 Million
Q1 2019 May 13, 2019	SELL	N/A	-6,760 Reduced 36.68%	11,670 $1.06 Million
Q4 2018 Feb 12, 2019	BUY	N/A	7,575 Added 69.78%	18,430 $1.32 Million
Q3 2018 Nov 13, 2018	BUY	N/A	8,355 Added 334.2%	10,855 $1.04 Million
Q4 2017 Feb 14, 2018	SELL	N/A	-860 Reduced 25.6%	2,500 $212,000
Q3 2017 Nov 15, 2017	BUY	N/A	3,360	3,360 $291,000

Others Institutions Holding XBI

# of Institutions

927

Shares Held

101M

Call Options Held

28.4M

Put Options Held

33.4M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Spdr Ser Tr Spdr S&P Biotech E Transaction History